This article describes the stgest command, which implements Gestimation (as proposed by Robins) to estimate the effect of a time-varying exposure on survival time, allowing for time-varying confounders.
Introduction
In this article, we describe the use of G-estimation to estimate causal effects. This method is used in studies where subjects are studied over a period of time, and the subject characteristics are measured at the start of the study (the baseline measurements) and on a number of subsequent occasions. Such studies are known as cohort studies by epidemiologists and as panel studies by social scientists. Subjects are followed-up until the occurrence of the outcome event, or until they are censored (e.g., because they reach the scheduled end of follow-up or because they withdraw from the study). The outcome event could be death from a particular cause, or the occurrence of a particular disease or other life event (e.g., the first successful job application for a panel of job seekers). The time between the start of follow-up and the occurrence of the outcome event is called the failure time.
Our aim is to identify factors associated with the occurrence of the outcome event.
We will call such factors exposures; these could be risk factors for disease (such as alcohol consumption) or treatment interventions (e.g., antiretroviral therapy for HIVinfected patients). We will deal only with binary exposure variables, for which subjects can always be classified as exposed or unexposed to the risk factor or treatment. The control of confounding is a fundamental problem in the analysis and interpretation of such studies. A confounding variable (confounder) is one that is associated with both the occurrence of the outcome and with the exposure of interest. For example, smoking will usually confound the association between alcohol consumption and the occurrence of cancer. Variables on the causal pathway between exposure and the outcome event should not be treated as confounders. For example, when estimating the effect of an antihypertensive (blood pressure-lowering) drug on the occurrence of heart disease, we should not control for blood pressure after the start of treatment. Controlling for a covariate that is intermediate on the pathway between exposure and outcome will estimate only the direct effect of the exposure (ignoring the effect mediated through the covariate). Exposure effects controlled for confounding may be estimated via stratification (e.g., using Mantel-Haenszel methods) or by using regression models that include both the exposure and the confounder(s) as covariates. We will focus on Cox and Weibull regression models for the analysis of cohort studies. When exposures and confounders are measured repeatedly, we may estimate their association with the outcome by splitting follow-up time into the periods between measurements, and assuming that the values measured at the start of the period remain constant until the next measurement occasion. We will refer to such estimates as time updated effects.
The problem addressed here is that standard methods for the analysis of cohort studies can lead to biased estimates of time-updated exposure effects. This is because of time-varying confounding. As defined by Mark and Robins (1993) , a covariate is a time-varying confounder for the effect of exposure on outcome if 1. past covariate values predict current exposure, and 2. current covariate value predicts outcome.
If, in addition, past exposure predicts current covariate value, then standard survival analyses with time-updated exposure effects will give biased exposure estimates, whether or not the covariate is included in the model.
For example, consider a study to estimate the effect of antiretroviral therapy (ART) on AIDS-free survival in patients infected with HIV. Markers of disease progression (e.g., CD4 counts) are used to decide when to administer ART, but are also affected by ART. CD4 count is a time-varying confounder for the effect of ART on survival times because 1. past values of CD4 count predict whether an individual is treated (condition 1), and 2. CD4 count predicts survival time (condition 2).
In addition, ART affects subsequent CD4 count, and so standard approaches to the analysis of time-updated exposure effects will give biased estimates of the effect of ART.
For example, analyses of the effect of ART on survival times could employ three possible strategies:
1. The crude estimate (not controlled for confounding) of the effect of ART will be biased, because ART tends to be given to individuals who are more immunosuppressed (their CD4 count is low) and who therefore tend to experience higher rates of AIDS and death.
2. Controlling for the baseline values of confounders such as CD4 count will still give biased estimates of the effect of ART, because this ignores the fact that individuals who started treatment after the start of the study will tend to be those who became immunosuppressed.
3. Controlling for time-updated measurements of confounders such as CD4 count will still give biased estimates of the effect of ART, because ART acts at least partly by raising CD4 counts. Such models would therefore ignore the effect of ART, which acts through raising CD4 count.
Methods
The method of G-estimation of causal effects in the presence of time-varying confounding was introduced by Robins; see, for example, Robins et al. (1992) , Witteman et al. (1998 ), or Tilling et al. (2002 . We briefly outline the method here.
The concept of the counterfactual failure time is fundamental to G-estimation. For subject i, the counterfactual failure time U i is defined as the failure time that would have occurred if the subject had been unexposed throughout follow-up. U i is called the counterfactual failure time because it is unobservable for subjects who were exposed at any time. For subjects who were unexposed throughout follow-up, U i is equal to their observed failure time. We assume that exposure accelerates failure time by a factor exp(−ψ), which we will call the causal survival time ratio. The purpose of the G-estimation procedure is to estimate the unknown parameter ψ. If ψ were known, then for a subject who experienced the outcome event and who was exposed throughout follow-up, U i would be equal to their observed failure time multiplied by exp(ψ), since Similarly, for any subject who experienced the outcome event at time T i , the counterfactual failure time U i,ψ could be derived from the observed failure time by
where e i (t) is 1 if subject i is exposed at time t and 0 if subject i is unexposed. As explained earlier, we assume that exposure is constant between measurement occasions. For example, if subject i experienced the outcome event at 5 years and was exposed for three of these, then
However, for the reasons given in the introduction, in the presence of time-varying confounding, ψ cannot be estimated from the data using standard methods (e.g., using a Weibull or other accelerated failure time model).
G-estimation provides estimates of ψ, allowing for time-varying confounding. The main assumption underlying the procedure is that there is no unmeasured confounding, which means that we have measured all variables that contribute to the process that determines whether a subject is exposed at each measurement occasion. If this assumption holds, then providing that we can account for the time varying confounding, associations between exposure and the outcome can be attributed unambiguously to the effect of the exposure. Conditional on this assumption (which cannot be tested using the data), individuals' exposure status at each measurement occasion will be independent of their counterfactual failure time U i . An example of this assumption is that, conditional on past weight, smoking status, blood pressure and cholesterol measurements (the confounders), the decision of an individual to quit smoking (the exposure) is independent of what his/her survival time would have been had he/she never smoked. Exposure does not have to be independent of subjects' actual life expectancy (smokers may choose to quit precisely because they recognize that smoking has already affected their health, and thus reduced their life expectancy).
The assumption of no unmeasured confounders implies that exposure at each measurement occasion is independent of U i . The G-estimation procedure therefore searches for the value ψ 0 for which exposure at each measurement occasion is independent of U i,ψ0 . This is done by fitting a logistic regression model relating measured exposure e it at each measurement occasion t to U i,ψ , controlling for all confounders {x ijt }:
The confounders in this regression model will typically include the other covariates at the current time point t, the values of the exposure and the other covariates at previous time-points and the values of the exposure and the other covariates at baseline. Subjects contribute an observation for each occasion at which the exposure and confounders were measured.
A series of logistic regression models defined by equation 2 are fitted for a range of different values of ψ. The G-estimate ψ 0 is the value of ψ for which the Wald statistic for α is zero; that is, the p-value is 1, meaning that there is no association between current exposure and U i,ψ0 . The upper and lower limits of the 95 percent confidence interval for ψ 0 are the two values for which the two-sided p-values for the Wald statistic of α are 0.05.
The G-estimate ψ 0 is minus the log of the "causal survival time ratio". Thus, exp(−ψ 0 ) estimates the ratio of the survival time of a continuously exposed person to that of an otherwise identical person who was never exposed. This ratio is the amount by which continuous exposure multiplies time to the outcome event. If exp(−ψ 0 ) > 1, then exposure is beneficial (i.e., exposure increases time to the outcome event). The causal interpretation is justified because (i) changes in exposure precede the occurrence of the outcome, and (ii) providing the assumption of no unmeasured confounders is valid, the estimated association between exposure and outcome can be attributed to the effect of exposure rather than to any confounding factor. Similar causal interpretations can be made from randomized controlled trials, in which criterion (i) is justified by the experimental design, and criterion (ii) by the randomized allocation of exposure (treatment).
Censoring
The counterfactual survival time, U i,ψ , can only be derived from the observed data for a subject who experiences the event. If the study has a planned end of follow-up (at time C i for individual i) that occurs before all subjects have experienced the outcome event, then some subjects' counterfactual failure times will not be estimable. If C i is independent of the counterfactual survival time, then this problem can be overcome by replacing U i,ψ with an indicator variable ∆ i,ψ that takes the value 1 if the event would have been observed both if individual i had been exposed throughout follow-up and if they had been unexposed throughout follow-up, and the value 0 otherwise; see Witteman et al. (1998) ,
where
is zero for all subjects who do not experience an event during follow-up, and may also be zero for some of those who did experience an event. Unlike U i,ψ , ∆ i,ψ is estimable for all subjects.
Competing risks
Subjects may also be censored by competing risks. For example, in the study of the effect of ART on AIDS-free survival, subjects could withdraw from the study because they felt too ill to participate in further follow-ups, or be withdrawn from the study because they were prescribed an alternative treatment. In each of these cases, censoring is not independent of the underlying counterfactual survival time. Thus, the above method for dealing with censoring by planned end of study cannot be used to deal with censoring by competing risks.
As outlined by Witteman et al. (1998) , censoring due to competing risks is dealt with by modeling the censoring mechanism, and using each individual's estimated probability of being censored to adjust the analysis. Multinomial logistic regression (using all available data) is used to relate the probability of being censored at each measurement occasion to the exposure and covariate history, and hence to estimate the probability of being uncensored to the end of the study for each individual. The inverse of this probability is used to weight the contributions of individuals to the logistic regression models used in the G-estimation process. This approach means that observations within the same individual are no longer independent, so the logistic regression models use robust standard errors allowing for clustering within individuals. This is equivalent to the procedure suggested by Witteman et al., to use a robust Wald test from a generalized estimating equation with an independence working correlation matrix. The confidence intervals obtained using this procedure are conservative.
Converting survival time ratios to hazard ratios
The parameter estimated by the G-estimation procedure, the causal survival time ratio, describes the association between exposure and survival using the accelerated failure time parameterization. In epidemiology, the more usual parameterization for survival analysis is that of proportional hazards. It is therefore useful to be able to express the causal survival time ratio in the proportional hazards parameterization. One obvious way to do this is via Weibull models, the only model that can be expressed in either parameterization.
The Weibull hazard function at time t is h(t) = φγt γ−1 , where φ is referred to as the scale parameter and γ as the shape parameter. If the vector of covariates x i does not affect γ, then the Weibull regression model can be written as either the usual epidemiological proportional hazards model
or as an accelerated failure time model,
where T i is the failure time for individual i, and has an extreme value distribution with scale parameter 1/γ. The Weibull shape parameter γ can thus be used to express results from the accelerated failure time parameterization as proportional hazards: θ = −β/γ. If the underlying survival times are assumed to follow a Weibull distribution, the Weibull shape parameter can therefore be used to express the G-estimated survival ratio as a hazard ratio for the exposure.
The stgest command
stgest estimates the effect of a time-varying exposure variable, expvar, on survival, accounting for possible confounding by the list of (time-varying or non time-varying) variables specified in confvars and, optionally, the lagged or baseline effects of one or more of these variables, specified using the lagconf() and baseconf() options.
Use of G-estimation requires a dataset in which exposures have been measured on at least two occasions, and the time until the occurrence of outcome of interest, or of censoring, is also recorded. The data should be in long st format, with subject identifier specified using the id option of the stset command, and each line of the dataset corresponding to an examination. We explain how to deal with censoring because of competing risks later. The visit option must be specified.
Syntax
lasttime(varname) must be specified unless all subjects experience the outcome event. It contains the time at which follow-up would have been completed for each patient, had they not experienced the outcome event.
range(numlist) provides the lower and upper ends of the range of estimates for the causal parameter to be considered in the estimation procedure. The default is −5 to 5. Unless the step() option is specified, the program conducts an interval bisection search for the best estimate of the causal parameter, together with corresponding upper and lower 95% confidence intervals.
step(#) is the increment to be used in the search for the best estimate of the causal parameter. If this option is used, the program conducts a grid search instead of an interval bisection search.
tol(#) is an integer (default 3) specifying the tolerance for the interval bisection search. The search ends when successive values of the estimate of the causal parameter differ by less than 10 −tol .
lagconf(varlist) gives a list of variables whose lagged confounding effect should be controlled for in the analysis. The lagged value is defined as the value at the previous occasion defined by visit(). Corresponding variables with names prefixed by L are created in the dataset.
firstvis(#) is the number of the first measurement occasion after which outcome events contribute to the analysis. If this is specified, then only follow-up from the examination after the baseline is considered in estimating the causal effect. By default firstvis() is the minimum value of visit(). If lagged confounders are to be used, then firstvis() must be at least one greater than the minimum value of visit().
baseconf(varlist) gives a list of variables whose baseline confounding effect should be controlled for in the analysis. The baseline value is defined as the minimum value of visit(). Corresponding variables with names prefixed by B are created in the dataset.
pnotcens(varlist) specifies a variable containing the cumulative probability of remaining uncensored by competing risks to the end of follow-up, for each individual. If this is not specified, it is assumed that there is no censoring by competing risks. This is derived from a logistic regression with censoring at each examination as the outcome.
idcens(varname) must be specified if pnotcens() is specified. idcens() is an indicator variable that shows whether the individual was censored due to competing risks (that is, for reasons other than the occurrence of the event of interest). Where there are competing risks, robust standard errors are used to take into account the fact that the probability of being censored is the same for all observations on a given individual.
saveres(filename) requests that the z-statistic for each value in range() be saved in filename. If this is not specified, no results are saved.
replace allows results previously saved in filename to be overwritten.
detail displays output from the regression model fitted at each iteration.
round(#) is rarely needed. It is used when there are problems in creating the indicator variable used in the logistic regression of exposure on counterfactual failure time, allowing for censoring.
Example
We will illustrate the use of the stgest command to estimate the effect of smoking on rates of heart disease, using data from the Caerphilly study, a longitudinal study of cardiovascular risk factors. Results will be compared with those from standard survival analyses. Participants (all of whom are men) were recruited between 1979 and 1983 (examination 1), when they were aged 44 to 60. Further examinations took place during the periods 1984 to 1988 (examination 2), 1989 to 1993 (examination 3), and 1993 to 1997 (examination 4). All subjects were followed until the end of 1998.
The dataset analyzed here is based on a total of 1756 subjects who had complete data at examinations 1 and 2. The outcome variable (mi) is the occurrence of either a myocardial infarction or death from coronary heart disease. Variable miexitdt gives the exit date for each subject, defined as the first (minimum) of (a) date of occurrence of the outcome, (b) date of death, (c) date of emigration, and (d) end of scheduled follow-up (31 December 1998). In the following displays, we will list data for ids 1021, 1022, and 1023. Id 1021 died from coronary heart disease on 18 June 1996, while ids 1022 and 1023 survived until the scheduled end of follow-up.
. Because we wish to control for the baseline effect of smoking and the other covariates, both standard survival analyses and G-estimation will begin at the date of examination 2. We therefore define a variable examdat2 containing this date for each id, and use this to create variable agebase (age at examination 2).
. gen edat2=examdat if phase==2 . egen examdat2=max(edat2), by(id) . format examdat2 %d . label var examdat2 "Date of 2nd exam (start of follow up for G estimation)" . drop edat2 . gen agebase=(examdat2-dob)/365.25 . replace agebase=agebase/10 . label var agebase "Age at baseline (10 year units)"
We can now stset the data and are ready for survival analyses and G-estimation. In these analyses, we will control for the following variables, which may confound the association between smoking and heart disease. To examine the effects of baseline smoking controlling for the baseline effects of other variables, we use the utility program makebase (supplied with the stgest package) to create variables (with names prefixed with B) containing the baseline value of all covariates:
. makebase cursmok hearta gout highbp diabet fib75 chol75 hbpsyst hbpdias /* */ obese thin, firstvis (1) We now use Cox regression to examine the effect of smoking at baseline, controlling for the baseline values of the covariates. This shows that subjects who were smokers had a substantially increased hazard of subsequent heart attacks. A second utility program makelag creates variables (with names prefixed with L) containing the lagged value of covariates (i.e., the value at the previous examination).
. makelag cursmok hearta gout highbp diabet fib75 chol75 hbpsyst hbpdias /* */ obese thin, firstvis (1) To examine the effect of current smoking, controlling for other confounders and for chronic damage caused by previous smoking, we would fit a model including the current, lagged, and baseline values of all covariates. Such a model appears to show that there is no effect of smoking. However, this analysis is not valid because of time-dependent confounding.
. stcox cursmok agebase hearta gout highbp diabet fib75 chol75 hbpsyst hbpdias > obese thin B* L* (output omitted ) To allow for time-dependent confounding, we use stgest. This first example ignores censoring due to competing risks, which is dealt with later. This analysis allows for the effect of current, lagged (option lagconf), and baseline (option baseconf) values of the covariates. We also supply the names of the variable indexing examination number (option visit), the first visit from which survival time is counted (option firstvis), the scheduled end of follow-up for each individual had they not been censored (option lasttime), the range over which we will search for values of ψ (option range), and the file in which our results will be saved (option saveres). The program automatically creates lagged and baseline values of the covariates with names prefixed by L and B, respectively, and lists these. It then outputs each value of ψ for which it fits the logistic regression (equation 2) and, finally, lists the values of ψ with their corresponding p-values and z statistics.
. stgest cursmok agebase fib75 hearta gout highbp diabet chol75 hbpsyst /* */ hbpdias obese thin, lagconf(fib75 hearta gout highbp diabet /* */ cursmok chol75 hbpsyst hbpdias obese thin) baseconf(fib75 hearta gout /* */ highbp cursmok chol75 diabet hbpsyst hbpdias obese thin) /* */ visit(visit) firstvis (2) It is possible that observations are dropped from the logistic regressions if a covariate predicts exposure perfectly. If this problem occurs, the above list of values for psi, pval, and z will include a column labeled error, with values of 1 corresponding to the logistic regressions in which the problem occurred. The cause of such problems can be investigated by specifying the detail option so that the logistic regression output for each iteration is displayed.
The program displays a graph of z against ψ (Figure 1 ). This should be approximately linear. The vertical lines show the values of ψ corresponding to the values of z closest to 0, 1.96, and −1.96 . If the graph is not linear, then the G-estimation process should be re-run using specified values of the range, because the search algorithm may be unreliable.
The estimated value of ψ 0 corresponds to the value of z closest to 0, with the 95% confidence interval corresponding to the values of z closest to −1.96 and 1.96. The final part of the output shows the causal survival time ratio exp(−ψ 0 ), with its 95% CI. To assess the influence of time-dependent confounding, we will compare these results with those from the corresponding Weibull regression:
. weibull _t cursmok agebase hearta gout highbp diabet fib75 chol75 hbpsyst /* */ hbpdias obese thin B* L* if visit>=2, dead(_d) t0 (_t0) Note that the hazard ratio for cursmok is, as is usually the case, almost identical to that from the Cox regression displayed earlier. The gesttowb utility uses the shape parameter γ from the Weibull regression (which is p in the Weibull output above) to convert the causal survival time ratio into a corresponding hazard ratio.
. gesttowb g-estimated hazard ratio 1.38 ( 1.04 to 1.60)
Because of time-dependent confounding, the standard survival analysis approach to the analysis of time-updated exposures underestimated the effect of smoking (hazard ratio 1.05 compared to the G-estimated hazard ratio of 1.38).
Allowing for competing risks
To allow for censoring due to competing risks, we first have to model the probability of being censored at each examination. Because we are examining survival from examination 2 onwards, no subject can be censored at examination 1. We model the probability of censoring using one model for examinations 2 and 3, and a separate model for examination 4. For examinations 2 and 3, we use a multinomial logit model with four outcomes: no censoring, MI (our outcome), death from another cause, and lost to follow-up. The model for examination 4 is similar, but there is no loss to follow-up after examination 4 (because it is the last planned examination). We then use the predicted probabilities (for each individual, from the model) of each outcome to calculate pcens, the estimated probability of being censored at a given examination, for each individual.
. mlogit cens phase3 agebase hearta gout highbp cursmok hbpsyst hbpdias /* */obese thin totchol fibrin if phase~=1&phase~=4 (output omitted )
Multinomial regression
Number of obs = 3285 LR chi2(36) = 154.79 Prob > chi2 = 0.0000 Log likelihood = -1633.1061
Pseudo R2 = 0.0452 (output omitted ) (Outcome cens==No is the comparison group) . predict pcens2 if e(sample), outcome(2) (option p assumed; predicted probability) (3092 missing values generated) . predict pcens3 if e(sample), outcome(3) (option p assumed; predicted probability) (3092 missing values generated) . gen pcens=pcens2+pcens3 (3092 missing values generated)
. mlogit cens agebase hearta gout highbp diabet cursmok hbpsyst hbpdias /* */obese thin totchol fibrin if phase==4 (output omitted ) We use the individual probability of not being censored at each examination to calculate pnotcens, the estimated probability for each individual of being uncensored to the end of examination 4.
. gen lpnocens=log(1-pcens) . egen sumpnoc=sum(lpnocens), by(id) . gen pnotcens=exp(sumpnoc) . label var pnotcens "Cumulative probability not censored"
We then use this probability of remaining uncensored to adjust the G-estimation for censoring due to competing risks. This involves specifying two further options: the probability of remaining uncensored to the end of the study (pnotcens) and an indicator variable for each id, idcens, which takes the value 1 if that subject is censored before the end of the study, and the value 0 otherwise. If these options are specified, the stgest command will weight the estimation procedure as described earlier, and use robust standard errors to account for the clustering this induces within individuals.
. stgest cursmok agebase fib75 hearta gout highbp diabet chol75 hbpsyst /* */hbpdias obese thin, /* */visit(visit) firstvis(2) lagconf(fib75 hearta gout highbp diabet /* */cursmok chol75 hbpsyst hbpdias obese thin) baseconf(fib75 hearta gout highbp/* */cursmok chol75 diabet hbpsyst hbpdias obese thin) lasttime(mienddat)/* */idcens(idcrcens) range(-1 1) pnotcens(pnotcens) saveres ( Again, to assess the influence of time-dependent confounding, we will compare these results with those from the corresponding Weibull regression. To adjust for censoring due to competing risks, we include in the model only those individuals who remained uncensored to the planned end of the study, and weight their contributions by the inverse of the probability of remaining uncensored to the planned end of the study. As before, we can use the shape parameter from the Weibull regression to express the G-estimation parameter as a hazard ratio:
